| Identification | Back Directory | [Name]
Cyclo(-Arg-Gly-Asp-D-Phe-Cys) | [CAS]
862772-11-0 | [Synonyms]
RGDfC
C(RGDFC)
Cyclo(-Arg-Gly-Asp-D-Phe-Cys)
CYCLO(ARG-GLY-ASP-D-PHE-CYS);RGDFC
c(RGDfC),cyclo(Arg-Gly-Asp-d-Phe-Cys)
4:PN:WO2020023462 PAGE:42 claimed protein
Cyclo(-Arg-Gly-Asp-D-Phe-Cys)
Acetate salt
Cyclo(-RGDfC), avb3 Integrin Binding Cyclic RGD Peptide
Cyclo(L-arginylglycyl-L-α-aspartyl-D-phenylalanyl-L-cysteinyl)
Cyclo(l-arginylglycyl-l-α-aspartyl-d-phenylalanyl-l-cysteinyl)
Cyclo(-RGDfC), avb3 Integrin Binding Cyclic RGD Peptide, c(RGDfC) | [Molecular Formula]
C24H34N8O7S | [MDL Number]
MFCD16876077 | [MOL File]
862772-11-0.mol | [Molecular Weight]
578.65 |
| Hazard Information | Back Directory | [Uses]
Cyclo(L-arginylglycyl-L-α-aspartyl-D-phenylalanyl-L-cysteinyl) is a peptide molecule which can be conjugated with hyperbranched amphiphilic block copolymer for cancer-targeted drug delivery and non-invasive positron emission tomography (PET) imaging in tumor-bearing mice. |
|
|